Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery

International Journal of Pharmaceutics

Volumn 363, Issue 1-2, 2008, Pages 58-65

  Matsumoto, Megumi ^a   Kishikawa, Reiko ^a   Kurosaki, Tomoaki ^a   Nakagawa, Hiroo ^a   Ichikawa, Nobuhiro ^a   Hamamoto, Tomoyuki ^a   To, Hideto ^a   Kitahara, Takashi ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cationic lipid; Gene delivery; Hybrid vector; Luciferase; Non viral vector; Polyethylenimine

Indexed keywords

AMMONIUM DERIVATIVE; CATION; DNA; LIPID; LIPOPLEX; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; NITROGEN; PHOSPHATE; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; COMPLEX FORMATION; CONTROLLED STUDY; DEGRADATION; DISSOCIATION; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; HUMAN; HUMAN CELL; HYBRID VECTOR; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMANS; LIVER; LUCIFERASES, FIREFLY; LUNG; MALE; MICE; NUCLEIC ACID CONFORMATION; PARTICLE SIZE; POLYETHYLENEIMINE; QUATERNARY AMMONIUM COMPOUNDS; SPLEEN; TRANSFECTION;

EID: 51649099200     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.07.010     Document Type: Article

References (30)

1. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7297-7301
2. Chen J.L., Wang H., Gao J.Q., Chen H.L., and Liang W.Q. Liposomes modified with polycation, characterization and transfection in vitro. Int. J. Pharm. 343 (2007) 255-261
3. Choosakoonkriang S., Lobo B.A., Koe G.S., Koe J.G., and Middaugh C.R. Biophysical characterization of PEI/DNA complexes. J. Pharm. Sci. 92 (2003) 1710-1722
4. Edelstein M.L., Abedi M.R., and Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J. Gene Med. 9 (2007) 833-842
5. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., and Danielsen M. Lipofection: a highly effocoent, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84 (1987) 7413-7417
6. Fillion M.C., and Phillips N.C. Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162 (1998) 159-170
7. Gao X., and Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2 (1995) 710-722
8. Gao X., and Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35 (1996) 1027-1036
9. García L., Buñuales M., Düzgüneş N., and Tros de Ilarduya C. Serum-resistant lipopolyplexes for gene delivery to liver tumour cells. Eur. J. Pharm. Biopharm. 67 (2007) 58-66
10. Godbey W.T., Wu K.K., and Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J. Control. Rel. 60 (1999) 149-160
11. Goldman C.K., Soroceanu L., Smith N., Gillespie G.Y., Shaw W., Burgess S., Bilbao G., and Curiel D.T. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat. Biotechnol. 15 (1997) 462-466
12. Goula D., Benoist C., Mantero S., Merlo G., Levi G., and Demeneix B.A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5 (1998) 1291-1295
13. Hama S., Akita H., Ito R., Mizuguchi H., Hayakawa T., and Harashima H. Quantitative comparison and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther. 13 (2006) 786-794
14. Hattori Y., and Maitani Y. Low-molecular-weight polyethylenimine enhanced gene transfer by cationic cholesterol-based nanoparticle vector. Biol. Pharm. Bull. 30 (2007) 1773-1778
15. Hedman M., Hartikainen J., Syvänne M., Stjernvall J., Hedman A., Kivelä A., Vanninen E., Mussalo H., Kauppila E., Simula S., Närvänen O., Rantala A., Peuhkurinen K., Nieminen M.S., Laakso M., and Ylä-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107 (2003) 2635-2637
16. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., and Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 6 (2004) 76-84
17. Kawakami S., Ito Y., Charoensit P., Yamashita F., and Hashida M. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J. Pharmacol. Exp. Ther. 317 (2006) 1382-1390
18. Kichler A., Leborgne C., Coeytaux E., and Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene Med. 3 (2001) 135-144
19. Kircheis R., Wightman L., and Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 53 (2001) 341-358
20. Lampela P., Elomaa M., Ruponen M., Urtti A., Männistö P.T., and Raasmaja A. Different synergistic roles of small polyethylenimine and Dosper in gene delivery. J. Control. Rel. 88 (2003) 173-183
21. Lechardeur D., Verkman A.S., and Lukacs G.L. Intracellular routing of plasmid DNA durring non-viral gene transfer. Adv. Drug Deliv. Rev. 57 (2005) 755-767
22. Lee C.H., Ni Y.H., Chen C.C., Chou C., and Chang F.H. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells. Biochim. Biophys. Acta 1611 (2003) 55-62
23. Li S., and Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4 (1997) 891-900
24. Pelisek J., Gaedtke L., DeRouchey J., Walker G.F., Nikol S., and Wagner E. Optimized lipoplex formulations for gene transfer to human colon carcinoma cells under in vitro conditions. J. Gene Med. 8 (2006) 186-197
25. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., and Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273 (1998) 7507-7511
26. Sorgi F.L., Bhattacharya S., and Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 4 (1997) 961-968
27. Tang M.X., and Szoka F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4 (1997) 823-832
28. Verma I.M., and Somia N. Gene therapy-promises, problems and prospects. Nature 389 (1997) 239-242
29. Wollenberg B., Kastenbauer, Mundl H., Schaumberg J., Mayer A., Andratschke M., Lang S., Pauli C., Zeidler R., Ihrler S., Löhrs, Naujoks K., and Rollston R. Gene therapy-phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol. Hum. Gene Ther. 10 (1999) 141-147
30. Xiong M.P., Laird Forrest M., Ton G., Zhao A., Davies N.M., and Kwon G.S. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials 28 (2007) 4889-4900